Literature DB >> 33283963

Rapid glucose rise reduces heart rate variability in adults with type 1 diabetes: A prospective secondary outcome analysis.

Max L Eckstein1,2, Othmar Moser1,2, Norbert J Tripolt1, Peter N Pferschy1, Anna A M Obermayer1, Harald Kojzar1, Alexander Mueller1,3, Farah Abbas1, Caren Sourij4, Harald Sourij1,5.   

Abstract

To investigate differences in heart rate variability (HRV) during oral glucose tolerance tests (OGTTs) in response to the rate of change in glucose and to different glycaemic ranges in individuals with type 1 diabetes. This was a single-centre, prospective, secondary outcome analysis in 17 individuals with type 1 diabetes (glycated haemoglobin 53 ± 6.3 mmol/L), who underwent two OGTTs (after 12 and 36 hours of fasting) investigating differences in HRV in response to rapid glucose increases/decreases and different glycaemic ranges during OGTT. Based on the rate of change in glucose level, the variables heart rate (P < 0.001), square root of the mean standard difference of successive R-R intervals (P = 0.002), percentage of pairs of R-R intervals with >50 ms difference (P < 0.001) and corrected QT interval (P = 0.04) were significantly altered, with HRV particularly reduced during episodes of rapid glucose rises. Glycaemic ranges during OGTT had no impact on HRV (P < 0.05). Individuals with type 1 diabetes showed no changes in HRV in response to different glycaemic ranges. HRV was dependent on the rate of change in glucose, especially rapid increases in glucose level.
© 2020 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autonomic regulation; heart rate variability; oral glucose tolerance test; type 1 diabetes

Year:  2021        PMID: 33283963     DOI: 10.1111/dom.14287

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  1 in total

1.  Acute Changes in Heart Rate Variability to Glucose and Fructose Supplementation in Healthy Individuals: A Double-Blind Randomized Crossover Placebo-Controlled Trial.

Authors:  Max Lennart Eckstein; Antonia Brockfeld; Sandra Haupt; Janis Ramon Schierbauer; Rebecca Tanja Zimmer; Nadine Bianca Wachsmuth; Beate Elisabeth Maria Zunner; Paul Zimmermann; Maximilian Erlmann; Barbara Obermayer-Pietsch; Felix Aberer; Othmar Moser
Journal:  Biology (Basel)       Date:  2022-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.